© 2026 Copyright Enamine
Back
Product details:
CAS
755037-03-7
Purity
95%
Regorafenib is a kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma.
Properties
Name
Regorafenib
Smiles
CNC(=O)C=1C=C(OC=2C=CC(NC(=O)NC=3C=CC(Cl)=C(C3)C(F)(F)F)=C(F)C2)C=CN1
Targets
Please log in to see this information
SDS
BAY73-4506 | CM4308 | Stivarga | regorafenib
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$46
2 mg
$48
5 mg
$49
10 mg
$50
15 mg
$51
20 mg
$52
25 mg
$57
30 mg
$63
35 mg
$71
40 mg
$78
45 mg
$85
50 mg
$92
75 mg
$98
100 mg
$POA
Quantity
1
Total amount
$ 49
BAY73-4506 | CM4308 | Stivarga | regorafenib
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1019206-88-2
0
